Correlation Between Iovance Biotherapeutics and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Fate Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Fate Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and Fate Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Iovance and Fate is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Fate Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.66 times more return on investment than Fate Therapeutics. However, Iovance Biotherapeutics is 1.52 times less risky than Fate Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 981.00 in Iovance Biotherapeutics on September 14, 2024 and sell it today you would lose (185.00) from holding Iovance Biotherapeutics or give up 18.86% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Iovance Biotherapeutics vs. Fate Therapeutics
Performance |
Timeline |
Iovance Biotherapeutics |
Fate Therapeutics |
Iovance Biotherapeutics and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iovance Biotherapeutics and Fate Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |